Juniper Pollen Allergy: Cedar Fever, Jun a 1, and How to Treat It

Cedar fever season in Central Texas runs from mid-December through February, with the most extreme pollen counts typically occurring in late December and January. This timing is unique among major North American aeroallergens — most tree pollens peak in spring (March–May), but Juniperus ashei mountain cedar pollinates in the middle of winter. Eastern red cedar (J. virginiana) extends Cupressaceae exposure into February and April across the eastern and southeastern US. Patients in Austin and San Antonio should begin pharmacotherapy preparation in November to be fully protected before the December pollen surge.

Cedar fever produces flu-like malaise — profound fatigue, headache, body aches, and a general sense of feeling unwell — because the intense systemic inflammatory response to extraordinarily high mountain cedar pollen concentrations mimics the systemic effects of a viral infection. However, body temperature remains normal (no true fever). The inflammatory mediators released by mast cells throughout the nasal mucosa, conjunctiva, and airways during peak cedar exposure produce systemic inflammatory signals that the body experiences as generalized illness. If your temperature exceeds 100.4°F during cedar season, you likely have a concurrent viral or bacterial infection and should see a physician.

Cedar fever in its classic severe form is primarily a Central Texas phenomenon, driven by the extraordinary concentration of Juniperus ashei (mountain cedar) in the Edwards Plateau Hill Country around Austin and San Antonio — where pollen counts routinely exceed 20,000 grains/m³. However, J. ashei pollen disperses for hundreds of miles during peak release events, and cedar-sensitized patients in Dallas, Houston, and surrounding regions can experience symptoms from long-range pollen transport. Eastern red cedar (J. virginiana) pollinates February through April across the eastern and southeastern US and can cause cedar-fever-like symptoms in sensitized patients. Western juniper species contribute to winter/early-spring symptoms in the Intermountain West.

Yes — subcutaneous immunotherapy (SCIT) for mountain cedar has been used by Texas allergists for decades and is the most established disease-modifying treatment for cedar fever. Clinical experience consistently shows meaningful cedar-season symptom reduction over a 3–5 year course, with benefit persisting after the course ends. SCIT is typically begun in spring or summer — outside cedar season — to allow gradual dose escalation without competing allergen exposure. The extract is often combined with other Texas allergens (oak, grass, mold) into a comprehensive regional immunotherapy mix. Most patients notice the first meaningful cedar-season improvement during their first treated December.

No — as of June 2026, no FDA-approved sublingual immunotherapy tablet (SLIT tablet) exists for any Cupressaceae pollen, including mountain cedar, in the United States. In Japan, Cedacure (Japanese cedar SLIT) is approved for Cryptomeria japonica — a related species — but this product is not available in the US. Japanese cedar (Cry j 1) and mountain cedar (Jun a 1) are cross-reactive Cupressaceae allergens, but the Japanese product is not approved for US use. US cedar-fever patients access SLIT through custom sublingual drops using standard tree-pollen extracts in an off-label formulation, supported by European trial evidence for tree-pollen SLIT broadly.

No — juniper/cedar pollen allergy (Cupressaceae, Jun a 1 pectate lyase) does NOT cause oral allergy syndrome to apple, cherry, hazelnut, peach, or other foods. The OAS connection to those foods is specific to birch pollen allergy via the PR-10 protein family (birch Bet v 1 cross-reacts with apple Mal d 1, cherry Pru av 1, etc.). Jun a 1 is a structurally different protein (pectate lyase, not PR-10) with no characterized food-protein counterparts. Cedar-fever patients can safely eat raw apples, cherries, and hazelnuts without concern related to their Cupressaceae sensitization.

Juniper, cedar, and cypress are all in the family Cupressaceae and share highly cross-reactive allergen proteins — so sensitization to any one species typically means cross-reactivity to all others in the family. 'Mountain cedar' is actually Juniperus ashei (a juniper, not a true cedar). True cedars are Cedrus species, a separate genus with less characterized allergen profiles. Cypress is Cupressus — its major allergen Cup a 1 is highly cross-reactive with juniper Jun a 1. Japanese cedar (Cryptomeria japonica) is another Cupressaceae member with Cry j 1 cross-reactivity. In clinical practice, Cupressaceae sensitization is treated as a family-wide cross-reactive group — a patient sensitized to mountain cedar will typically react to cypress, eastern red cedar, and Japanese cedar exposure as well.

Juniperus ashei (mountain cedar) is one of the few major North American tree aeroallergens that pollinates in winter rather than spring. Unlike birch, oak, and maple — which flower in March through May — mountain cedar's catkins develop in fall and release pollen from mid-December through February. This winter pollination window likely evolved as an advantage in the competition for wind-mediated pollination, when other tree species are not releasing competing pollen. The result is that Central Texas residents experience their worst allergy season during what most of the country considers a pollen-free winter, leading to confusion, misdiagnosis as influenza, and delays in appropriate treatment.

Eastern red cedar (Juniperus virginiana) and mountain cedar (Juniperus ashei) are different juniper species in the same Cupressaceae family, with strong cross-reactivity through shared pectate lyase allergen proteins. Mountain cedar (J. ashei) is by far the more allergenic — it is approximately 20 times more allergenic than Mediterranean cypress, produces massive pollen loads, and is responsible for the severe cedar fever classic to Central Texas. Eastern red cedar (J. virginiana) is more widely distributed across the eastern and southeastern US, pollinates slightly later (February–April), and produces a less intense but geographically broader allergenic burden. Patients sensitized to mountain cedar are virtually always cross-reactive to eastern red cedar and vice versa.

Mountain cedar pollen differs from other major tree pollens in several ways. First, its season: December through February, while most tree pollens peak in spring (March–May). Second, its volume: Austin routinely records counts above 20,000 grains per cubic meter — among the highest for any aeroallergen globally — compared to typical birch or oak peaks of 1,000–3,000 grains/m³. Third, its allergen protein: Jun a 1 is a pectate lyase enzyme, structurally distinct from birch PR-10 proteins or grass beta-expansins — so cedar allergy produces different cross-reactivity patterns and does not cause the food OAS that birch allergy produces. Fourth, its geographic concentration: its source trees are heavily concentrated in one region, making the exposure gradient between Austin and other Texas cities extreme.